These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 21162342)
1. Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs. Patrono C Bull Mem Acad R Med Belg; 2010; 165(1-2):115-23; discussion 124. PubMed ID: 21162342 [No Abstract] [Full Text] [Related]
3. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Hermann M; Ruschitzka F Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196 [TBL] [Abstract][Full Text] [Related]
5. What price pain relief? Hochman JS; Shah NR Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335 [No Abstract] [Full Text] [Related]
6. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Hermann M; Ruschitzka F Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular complications of non-steroidal anti-inflammatory drugs. Fosslien E Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252 [TBL] [Abstract][Full Text] [Related]
8. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Woodruff T Intern Med J; 2006 Dec; 36(12):797-8; author reply 798-9. PubMed ID: 17096747 [No Abstract] [Full Text] [Related]
12. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. ; Wilcox CM; Allison J; Benzuly K; Borum M; Cryer B; Grosser T; Hunt R; Ladabaum U; Lanas A; Paulus H; Regueiro C; Sandler RS; Simon L Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1082-9. PubMed ID: 16877048 [No Abstract] [Full Text] [Related]
13. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Mitchell JA; Warner TD Nat Rev Drug Discov; 2006 Jan; 5(1):75-86. PubMed ID: 16485347 [TBL] [Abstract][Full Text] [Related]
14. [NSAIDs or coxibs: benefits and gastrointestinal vs. cardiovascular effects]. Ballesteros Amozurrutia MA Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():22-5. PubMed ID: 17037763 [No Abstract] [Full Text] [Related]
15. [Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases]. Guo ZR Yao Xue Xue Bao; 2005 Nov; 40(11):967-9. PubMed ID: 16499077 [No Abstract] [Full Text] [Related]
16. Cardiovascular adverse reactions from NSAIDs are more than COX-2 inhibition alone. Rainsford KD Rheumatology (Oxford); 2010 May; 49(5):834-6. PubMed ID: 20097907 [No Abstract] [Full Text] [Related]
17. Aspirin, arachidonic acid and the regulation of mood. Bazinet RP Prostaglandins Leukot Essent Fatty Acids; 2010 Jan; 82(1):7-8. PubMed ID: 19910174 [No Abstract] [Full Text] [Related]
18. The murky waters of the coxibs: a review of the current state of play. Ostor AJ; Hazleman BL Inflammopharmacology; 2005; 13(4):371-80. PubMed ID: 16354390 [TBL] [Abstract][Full Text] [Related]
19. COX-2 inhibitors: pharmacological data and adverse effects. Mattia C; Coluzzi F Minerva Anestesiol; 2005; 71(7-8):461-70. PubMed ID: 16012420 [TBL] [Abstract][Full Text] [Related]
20. The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks. Cairns JA Can J Cardiol; 2007 Feb; 23(2):125-31. PubMed ID: 17311118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]